Join us for an afternoon of provocative discussions addressing the convergence of life sciences and technology within a highly regulated business environment. Network with industry peers.
Who should attend?
Executives, Investors, General Counsel and Company Counsel
- Jaron Lanier is a computer philosophy writer, computer scientist and visual artist. He has been on the cusp of technological innovation from its infancy to the present. Lanier is credited with popularizing the term “virtual reality” and is also a bestselling author of You Are Not a Gadget, A Manifesto (2010) and Who Owns the Future? (2013). In 2010, Time Magazine named Lanier one of the 100 most influential people in the world.
To Be Confirmed
- Mark Ginestro, Principal, Healthcare and Life Sciences, Strategy, KPMG
- Matthew Gunnison, Executive Director, New Business Creation, GE Ventures
- Kathy Hibbs, Chief Legal and Regulatory Officer, 23andMe
- Michael Listgarten, Senior Associate General Counsel, Genentech
- Kevin Marks, Vice President, General Counsel, Roche Molecular Diagnostics
- Sarah Jane Militello, Director of Operations, UCSF | Samsung Digital Health Innovation Lab
- Vicki Seyfort Margolis, CEO, My Own Med
- Josh Stein, CEO & Co-Founder, AdhereTech
- Michael Taborn, Lead Platform Architect for the Healthcare Segment, Intel Internet of Things (IOTG)
Navigating the Digital Health OpportunityDigital health, which includes diverse technologies such as health information software, mobile health applications (mHealth apps), wearable devices, networked medical devices and combination drug/devices that operate on or connect to the Internet, presents significant privacy and security challenges. As technology outpaces regulation, companies must deal with issues such as consumer consent, data ownership, use and security. In this session learn how to think strategically about these issues and hear practical advice on how to mitigate a company’s risks and promote consumer trust.
Managing the Blind Spot – Cross-Industry Alliances
As companies explore new avenues outside their core competency, many consider strategic partnerships to bring industry expertise to their new ventures. Managing or collaborating with third parties may uncover issues or gaps in their core business. Hear from an experienced panel on lessons learned on how to best manage these “blind spots.”
Monetizing Big Data
Big Data is poised to drive innovation and monetization opportunities that may disrupt current structures such as the clinical study process. Innovators seek to use these data sets for efficiencies, new research and product development. But the disruptiveness of Big Data can mask how hard it is for companies to make money from data. Even the best business model can be derailed by questions about data rights, governmental regulation and other pitfalls. Panelists from diverse perspectives will explore what works, what fails and why. Hear how to manage these risks and turn them to your advantage.
Bay to Beltway: Why Regulatory Strategy Matters to Innovators
Integrating a regulatory strategy into business planning is important. The purpose of regulation is to serve as a brake on innovation – it’s a feature of the system, not a bug. Understanding what rules apply to a new product or service when the regulatory scheme is complex and fluid requires an investment in the right resources at the right time. If you’re paying attention to the right information and know how to decode it, regulatory behavior is predictable. Listen to beltway insiders discuss their stories about smart engagement – how to read signals from Washington, when and how to engage with policymakers, when to fight and when to fold.
Sidley Austin LLP is an accredited MCLE provider in CA, NY and IL. CLE credit for this program is pending.